121 related articles for article (PubMed ID: 37071410)
1. Co-Encapsulation of Hydrophilic and Hydrophobic Drugs into Human H Chain Ferritin Nanocarrier Enhances Antitumor Efficacy.
Ning C; Dong Y; Yang K; Li X; Wang F; Zhang Y
ACS Biomater Sci Eng; 2023 May; 9(5):2572-2583. PubMed ID: 37071410
[TBL] [Abstract][Full Text] [Related]
2. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
3. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
Liang M; Fan K; Zhou M; Duan D; Zheng J; Yang D; Feng J; Yan X
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14900-5. PubMed ID: 25267615
[TBL] [Abstract][Full Text] [Related]
4. Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.
Wang Z; Zhao Y; Zhang S; Chen X; Sun G; Zhang B; Jiang B; Yang Y; Yan X; Fan K
Theranostics; 2022; 12(4):1800-1815. PubMed ID: 35198074
[No Abstract] [Full Text] [Related]
5. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobicity-enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells.
Incocciati A; Kubeš J; Piacentini R; Cappelletti C; Botta S; Bertuccini L; Šimůnek T; Boffi A; Macone A; Bonamore A
Protein Sci; 2023 Dec; 32(12):e4819. PubMed ID: 37883077
[TBL] [Abstract][Full Text] [Related]
7. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
9. ERK-Peptide-Inhibitor-Modified Ferritin Enhanced the Therapeutic Effects of Paclitaxel in Cancer Cells and Spheroids.
Dong Y; Ma Y; Li X; Wang F; Zhang Y
Mol Pharm; 2021 Sep; 18(9):3365-3377. PubMed ID: 34370483
[TBL] [Abstract][Full Text] [Related]
10. One-step construction of ferritin encapsulation drugs for cancer chemotherapy.
Inoue I; Chiba M; Ito K; Okamatsu Y; Suga Y; Kitahara Y; Nakahara Y; Endo Y; Takahashi K; Tagami U; Okamoto N
Nanoscale; 2021 Jan; 13(3):1875-1883. PubMed ID: 33439183
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers.
Kurzątkowska K; Pazos MA; Herschkowitz JI; Hepel M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572999
[TBL] [Abstract][Full Text] [Related]
13. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
[TBL] [Abstract][Full Text] [Related]
14. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
15. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
16. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded polypeptide nanorods based on electrostatic interactions for cancer therapy.
Zhang L; Zhang P; Zhao Q; Zhang Y; Cao L; Luan Y
J Colloid Interface Sci; 2016 Feb; 464():126-36. PubMed ID: 26609932
[TBL] [Abstract][Full Text] [Related]
19. The anti-tumor and renoprotection study of E-[c(RGDfK)
Zhang B; Zhang Y; Dang W; Xing B; Yu C; Guo P; Pi J; Deng X; Qi D; Liu Z
J Nanobiotechnology; 2022 Sep; 20(1):425. PubMed ID: 36153589
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
